ENLV
Enlivex Therapeutics Ltd.
Company Overview
| Mkt Cap | $25.76M | Price | $1.05 |
| Volume | 62.22K | Change | -0.48% |
| P/E Ratio | -0.9 | Open | $1.06 |
| Revenue | -- | Prev Close | $1.05 |
| Net Income | $-29.1M | 52W Range | $0.81 - $2.10 |
| Div Yield | N/A | Target | $10.00 |
| Overall | 20 | Value | -- |
| Quality | 23 | Technical | 18 |
No chart data available
Stock Overview
Updated DailyEnlivex Therapeutics Ltd. (ENLV) is a leading Healthcare company in the Biotechnology industry, currently trading at $1.04 with a market capitalization of $25.76 million. The stock is approaching its 52-week lows, suggesting potential value opportunity, demonstrating concerning quality fundamentals with a MarketXLS quality score of 23.
Today's trading session shows ENLV with a volume of 62K shares. The stock opened up 0.95% from yesterday's close of $1.05. Current analyst estimates project earnings of $-0.45 per share for this year, with next year targeting $-0.57.
ENLV demonstrates concerning technical signals based on technical analysis. The company trades on the NSC exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for ENLV include concerning overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 856.9%. The stock shows neutral valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 11:17 PM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ENLV | $1.05 | -0.5% | 62.22K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Enlivex Therapeutics Ltd. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW